Details for Patent: 8,685,957
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 8,685,957 protect, and when does it expire?
Patent 8,685,957 protects ZERBAXA and is included in one NDA.
Summary for Patent: 8,685,957
| Title: | Tazobactam arginine compositions |
| Abstract: | This disclosure provides compositions containing solid forms of tazobactam arginine, and methods of manufacturing and using these compositions. |
| Inventor(s): | Lai; Jan-Ji (Westborough, MA), Gu; Jian-Qiao (Lexington, MA), Pathare; Pradip M. (Lexington, MA), Jurkauskas; Valdas (Cambridge, MA), Terracciano; Joseph (Concord, MA), Damour; Nicole Miller (Belmost, MA) |
| Assignee: | Cubist Pharmaceuticals, Inc. (Lexington, MA) |
| Application Number: | 13/828,534 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 8,685,957
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;INTRAVENOUS | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | METHODS OF TREATING BACTERIAL ILLNESSES | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
